2 research outputs found
ΠΠ‘ΠΠΠΠΠΠΠ‘Π’Π ΠΠΠ ΠΠΠΠΠΠ― Π‘ΠΠΠΠΠΠ¬ΠΠ«Π₯ ΠΠΠΠ€ΠΠ’ΠΠ§ΠΠ‘ΠΠΠ₯ Π£ΠΠΠΠ ΠΠ Π ΠΠΠ ΠΠΠ§ΠΠΠ ΠΠΠΠΠΠΠΠ ΠΠΠΠ
Introduction. Each tenth tumor of skin is melanoma. Presence of tumor cells in sentinel lymph node influenced the medical tactics.The objective of the research was to study the metastasis of skin melanoma into the clinically negative regional lymph nodes.Material and methods. Histological, immunohistochemical, cytological and immunocytochemical methods were used to study biopsies of regional lymph nodes in 60 patients with skin melanoma.Results. 5 % of patients were diagnosed with melanoma in situ, 15 % β Π’1, 28.3 % β Π’2, 23.3 % β Π’3, 28.3 % β Π’4. At outflow of the lymph through 1 collector, the metastases in sentinel lymph node (SLN) was defined in 51 %, through 2 collectors β in 81.8 % of cases. Tumor cells damaged single lymph node in 35.3 % of cases, two and more lymph nodes in 64.7 % of cases. Metastases in SLN with formation of secondary tumor at the T1 melanoma were observed at 11.1 %, T2 β 5.9 %, T3 β 21.4 %, T4 β 47.1 % of studies. Clusters of cells or isolated cells of melanoma in SLN at Π’1 were noted in 22.2 %, at Π’2 β in 41.2 %, at Π’3 β in 42.9 %, at Π’4 β in 35.3 % of cases. At outflow of lymph through 1 collector, metastasises of melanoma in non-sentinel lymph nodes (NSLN) were revealed in 24 %, through 2 collectors β in 44.4 % of cases. Secondary changes of NSLN were noted in 16.7 % of cases of defeat of single SLN, in 31.8 % of cases of defeat of two and more SLN. Metastases of melanoma were revealed in 69.2 % of cases of formation of secondary tumor and in 4.8 % of cases of presence of clusters in SLN in removed NSLN.Conclusion. At increase of Π’melanoma of the skin, the quantity of sentinel lymph nodes with reactive changes decreased, and their number with metastases increased. Metastatic defeat of sentinel lymph nodes at outflow of lymph through 2 lymph collectors in two and more SLN and NSLN exceeded the defeat of SLN at outflow of lymph through 1 lymph collector in single lymph nodes. The use of immunocytochemical method of research allowed to expand pathomorphological verification of metastatic defeat of sentinel lymph nodes by 66.7%.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠ°ΠΆΠ΄Π°Ρ 10-Ρ ΠΎΠΏΡΡ
ΠΎΠ»Ρ ΠΊΠΎΠΆΠΈ β ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ°, Π½Π° ΠΏΠ»Π°Π½ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΊΠΎΡΠΎΡΠΎΠΉ Π²Π»ΠΈΡΠ΅Ρ Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ Π² ΡΠΈΠ³Π½Π°Π»ΡΠ½ΠΎΠΌ Π»ΠΈΠΌΡΠΎΡΠ·Π»Π΅.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ ΠΊΠΎΠΆΠΈ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠ΅ ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ·Π»Ρ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ, ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ, ΡΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΡΠΈΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ Π±ΠΈΠΎΠΏΡΠ°ΡΡ ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ² 60 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ ΠΊΠΎΠΆΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ 5 % ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Π° ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ° Π² ΡΡΠ°Π΄ΠΈΠΈ in situ, Ρ 15 % β Π’1, Ρ 28,3 % β Π’2, Ρ 23,3 % β Π’3, Ρ 28,3 % β Π’4. ΠΡΠΈ ΠΎΡΡΠΎΠΊΠ΅ Π»ΠΈΠΌΡΡ ΡΠ΅ΡΠ΅Π· 1 Π»ΠΈΠΌΡΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Ρ Π² ΡΠΈΠ³Π½Π°Π»ΡΠ½ΠΎΠΌ Π»ΠΈΠΌΡΠΎΡΠ·Π»Π΅ (Π‘ΠΠ£) ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΠ»ΠΈ Π² 51 %, ΡΠ΅ΡΠ΅Π· 2 Π»ΠΈΠΌΡΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡΠ° β Π² 81,8 % ΡΠ»ΡΡΠ°Π΅Π². Π 35,3 % ΡΠ»ΡΡΠ°Π΅Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ ΠΏΠΎΡΠ°ΠΆΠ°Π»ΠΈ Π΅Π΄ΠΈΠ½ΠΈΡΠ½ΡΠΉ Π»ΠΈΠΌΡΠΎΡΠ·Π΅Π», Π² 64,7 % β 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π»ΠΈΠΌΡΠΎΡΠ·Π»Π°. ΠΠ΅ΡΠ°ΡΡΠ°Π·Ρ Π² Π‘ΠΠ£ Ρ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π²ΡΠΎΡΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΏΡΠΈ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ΅ Π’1 Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈ Π² 11,1 %, Π’2 β Π² 5,9 %, Π’3 β Π² 21,4 %, Π’4 β Π² 47,1 % ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. Π‘ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠΎ ΡΠΈΠΏΡ ΠΊΠ»Π°ΡΡΠ΅ΡΠ° ΠΈΠ»ΠΈ ΡΠ°Π·ΡΠΎΠ·Π½Π΅Π½Π½ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ Π² Π‘ΠΠ£ ΠΏΡΠΈ Π’1 ΠΎΡΠΌΠ΅ΡΠ΅Π½Ρ Π² 22,2 %, ΠΏΡΠΈ Π’2 β Π² 41,2 %, ΠΏΡΠΈ Π’3 β Π² 42,9 %, ΠΏΡΠΈ Π’4 β Π² 35,3 % ΡΠ»ΡΡΠ°Π΅Π². ΠΡΠΈ ΠΎΡΡΠΎΠΊΠ΅ Π»ΠΈΠΌΡΡ ΡΠ΅ΡΠ΅Π· 1 ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Ρ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ Π² Π½Π΅ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠΎΡΠ·Π»Π°Ρ
(ΠΠ‘ΠΠ£) Π²ΡΡΠ²Π»Π΅Π½Ρ Π² 24 %, ΡΠ΅ΡΠ΅Π· 2 ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡΠ° β Π² 44,4 % ΡΠ»ΡΡΠ°Π΅Π². ΠΡΠΎΡΠΈΡΠ½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΠ‘ΠΠ£ ΠΎΡΠΌΠ΅ΡΠΈΠ»ΠΈ Π² 16,7 % ΡΠ»ΡΡΠ°Π΅Π² ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π΅Π΄ΠΈΠ½ΠΈΡΠ½ΠΎΠ³ΠΎ Π‘ΠΠ£, Π² 31,8 % Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΉ β ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π‘ΠΠ£. Π 69,2 % ΡΠ»ΡΡΠ°Π΅Π² ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π²ΡΠΎΡΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ Π² 4,8 % Π½Π°Π»ΠΈΡΠΈΡ ΠΊΠ»Π°ΡΡΠ΅ΡΠΎΠ² Π² Π‘ΠΠ£ Π² ΡΠ΄Π°Π»Π΅Π½Π½ΡΡ
ΠΠ‘ΠΠ£ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Ρ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΡΠΈ Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΠΈ Π’ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ ΠΊΠΎΠΆΠΈ ΡΠΌΠ΅Π½ΡΡΠ°Π»ΠΎΡΡ ΡΠΈΡΠ»ΠΎ ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ² Ρ ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΡΠΌΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΠΌΠΈ, ΠΈ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π»Π° ΠΈΡ
ΡΠΈΡΠ»Π΅Π½Π½ΠΎΡΡΡ Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Π°ΠΌΠΈ. ΠΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ² ΠΏΡΠΈ ΠΎΡΡΠΎΠΊΠ΅ Π»ΠΈΠΌΡΡ ΡΠ΅ΡΠ΅Π· 2 Π»ΠΈΠΌΡΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡΠ° Π² 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π‘ΠΠ£ ΠΈ ΠΠ‘ΠΠ£ ΠΏΡΠ΅Π²ΡΡΠ°Π»ΠΎ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ Π‘ΠΠ£ ΠΏΡΠΈ ΠΎΡΡΠΎΠΊΠ΅ Π»ΠΈΠΌΡΡ ΡΠ΅ΡΠ΅Π· 1 Π»ΠΈΠΌΡΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡΠΎΡ Π² Π΅Π΄ΠΈΠ½ΠΈΡΠ½ΡΠ΅ Π»ΠΈΠΌΡΠΎΡΠ·Π»Ρ. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΠΈΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΎ Π½Π° 66,7 % ΡΠ°ΡΡΠΈΡΠΈΡΡ ΠΏΠ°ΡΠΎΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ Π²Π΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ²
FEATURES OF DEFEATS OF SENTINEL LYMPH NODES AT PRIMARY MELANOMA OF SKIN
Introduction. Each tenth tumor of skin is melanoma. Presence of tumor cells in sentinel lymph node influenced the medical tactics.The objective of the research was to study the metastasis of skin melanoma into the clinically negative regional lymph nodes.Material and methods. Histological, immunohistochemical, cytological and immunocytochemical methods were used to study biopsies of regional lymph nodes in 60 patients with skin melanoma.Results. 5 % of patients were diagnosed with melanoma in situ, 15 % β Π’1, 28.3 % β Π’2, 23.3 % β Π’3, 28.3 % β Π’4. At outflow of the lymph through 1 collector, the metastases in sentinel lymph node (SLN) was defined in 51 %, through 2 collectors β in 81.8 % of cases. Tumor cells damaged single lymph node in 35.3 % of cases, two and more lymph nodes in 64.7 % of cases. Metastases in SLN with formation of secondary tumor at the T1 melanoma were observed at 11.1 %, T2 β 5.9 %, T3 β 21.4 %, T4 β 47.1 % of studies. Clusters of cells or isolated cells of melanoma in SLN at Π’1 were noted in 22.2 %, at Π’2 β in 41.2 %, at Π’3 β in 42.9 %, at Π’4 β in 35.3 % of cases. At outflow of lymph through 1 collector, metastasises of melanoma in non-sentinel lymph nodes (NSLN) were revealed in 24 %, through 2 collectors β in 44.4 % of cases. Secondary changes of NSLN were noted in 16.7 % of cases of defeat of single SLN, in 31.8 % of cases of defeat of two and more SLN. Metastases of melanoma were revealed in 69.2 % of cases of formation of secondary tumor and in 4.8 % of cases of presence of clusters in SLN in removed NSLN.Conclusion. At increase of Π’melanoma of the skin, the quantity of sentinel lymph nodes with reactive changes decreased, and their number with metastases increased. Metastatic defeat of sentinel lymph nodes at outflow of lymph through 2 lymph collectors in two and more SLN and NSLN exceeded the defeat of SLN at outflow of lymph through 1 lymph collector in single lymph nodes. The use of immunocytochemical method of research allowed to expand pathomorphological verification of metastatic defeat of sentinel lymph nodes by 66.7%